Crescita Therapeutics™ Announces Director Election Results of its Annual General Meeting

MISSISSAUGA, ON, June 20, 2017 /CNW/ - Crescita Therapeutics Inc. (TSX:CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms, today announced that at its 2017 Annual and Special Meeting of Shareholders held in Toronto, all nominees listed in the management proxy circular dated May 17, 2017 were elected as directors of the Company.

The detailed results of the votes by proxy are as follows:

Director Nominees

NUMBER OF SHARES

PERCENTAGE OF VOTES CAST

FOR

WITHHELD

FOR

WITHHELD

Daniel N. Chicoine

5,308,089

237,704

95.71

4.29

David A. Copeland

5,332,506

213,287

96.15

3.85

Anthony E. Dobranowski

5,343,730

202,063

96.36

3.64

John C. London

5,308,318

237,475

95.72

4.28

Samira Sakhia

5,367,927

177,866

96.79

3.21

Thomas Schlader

5,357,071

188,722

96.60

3.40

About Crescita Therapeutics Inc.
Crescita (TSX:CTX) is a publicly traded, Canadian commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the skin.  For additional information, please visit www.crescitatherapeutics.com.

SOURCE Crescita Therapeutics Inc.

For further information: PLEASE CONTACT: Investor Relations, Email: ir@crescitatx.com

RELATED LINKS
http://www.crescitatherapeutics.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890